Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Construction in Progress: 2018-2020

Historic Construction in Progress for Legend Biotech (LEGN) over the last 3 years, with Dec 2020 value amounting to $33.6 million.

  • Legend Biotech's Construction in Progress rose 1082.74% to $33.6 million in Q4 2020 from the same period last year, while for Dec 2020 it was $33.6 million, marking a year-over-year increase of 1082.74%. This contributed to the annual value of $33.6 million for FY2020, which is 1082.74% up from last year.
  • Legend Biotech's Construction in Progress amounted to $33.6 million in FY2020, which was up 1,082.74% from $2.8 million recorded in FY2019.
  • Over the past 5 years, Legend Biotech's Construction in Progress peaked at $33.6 million during FY2020, and registered a low of $2.6 million during FY2018.
  • Over the past 3 years, Legend Biotech's median Construction in Progress value was $2.8 million (recorded in 2019), while the average stood at $13.0 million.
  • Data for Legend Biotech's Construction in Progress shows a peak YoY skyrocketed of 1,082.74% (in 2020) over the last 5 years.
  • Yearly analysis of 3 years shows Legend Biotech's Construction in Progress stood at $2.6 million in 2018, then climbed by 8.22% to $2.8 million in 2019, then spiked by 1,082.74% to $33.6 million in 2020.